Cyclosporine A treatment in patients with Alport syndrome: A single-center experience

Pediatric Nephrology

Volumn 25, Issue 7, 2010, Pages 1269-1275

  Massella, Laura ^a   Muda, Andrea Onetti ^b   Legato, Antonia ^a   Di Zazzo, Giacomo ^a   Giannakakis, Kostas ^c   Emma, Francesco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alport syndrome; Angiotensin converting enzyme inhibitors; Angiotensin receptor blockers; Cyclosporine A; Glomerular basement membrane; Hereditary nephritis

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CLONIDINE; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; LABETALOL; RAMIPRIL;

ALPORT SYNDROME; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEINURIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; NEPHRITIS, HEREDITARY; PROTEINURIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954474511     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1484-3     Document Type: Article

References (25)

1. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227
2. Tryggvason K, Zhou J, Hostikka SL, Shows TB (1993) Molecular genetics of Alport syndrome. Kidney Int 43:38-44
3. Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C (1995) Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:142-147
4. Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grünfeld JP, Palcoux JB, Gubler MC, Antignac C (1998) Determination of the genomic structure of the COL4A4 gene and novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 63:1329-1340
5. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP (1997) Autosomal dominant Alport syndrome linked to the type IV collagen alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12:1595-1599
6. Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, Bergesio F, Amoroso A, Savoldi S, Pennesi M, Giachino D, Rombolà G, Fogazzi GB, Rosatelli C, Martinhago CD, Carmellini M, Mancini R, Di Costanzo G, Longo I, Renieri A, Mari F (2009) Autosomal dominant Alport Syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant 24:1464-1471
7. Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M (2002) COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61:1947-1956
8. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 14:2603-2610
9. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649-657
10. Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatr Nephrol 19:271-275
11. Kunz R, Friedrich C, Wolbers M, Mann JF (2008) Meta-analysis: effects of monotherapynand combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med 148:30-48
12. Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G (2008) Antiproteinuric response to dual blockade of the renin angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. Am J Kidney Dis 52:475-485
13. Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G (2008) Role of remission clinics in the longtudinal treatment of CKD. J Am Soc Nephrol 19:1213-1224
14. Callis L, Vila A, Carrera M, Nieto J (1999) Long-term effect of cyclosporine A in Alport's Syndrome. Kidney Int 55:1051-1056
15. Charbit M, Gubler MC, Dechaux M, Gagnadoux MF, Grünfeld JP, Niaudet P (2007) Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol 22:57-63
16. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34:571-590
17. Mihatsch MJ, Antonovych T, Bohman SO, Habib R, Helmchen U, Noel LH, Olsen S, Sibley RK, Kemény E, Feutren G (1994) Cyclosporine A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol 41:23-32
18. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931-938
19. Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F, for the ESCAPE Trial Group (2009) Strict blood pressure control and renal failure progression in children. N Engl J Med 361:1639-1650
20. Chen D, Jefferson B, Harvey SJ, Zheng K, Gartley CJ, Jacobs RM, Thorner PS (2003) Cyclopsorine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 14:690-698
21. Khanna A, Kapur S, Sharma V, Li B, Suthanthiran M (1997) In vivo hyperexpression of transforming growth factor-beta 1 in mice: stimulation by cyclosporine. Transplantation 63:1037-1039 (Pubitemid 27173034)
22. Islam M, Burke JF Jr, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K (2001) Effect of anti-trasforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 59:498-506
23. Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63:438-446
24. Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F (2009) Risk factors for Cyclosporin A nephrotoxicity in children with steroiddependant nephrotic syndrome. Clin J Am Soc Nephrol 4:1409-1416
25. Gross O, Kashtan CE (2009) Treatment of Alport syndrome: beyond animal models. Kidney Int 76:599-603